Table 2 Patient characteristics in the anticoagulation groups
No anticoagulation n = 13 | Heparin n = 8 | Citrate n = 17 | P | |
|---|---|---|---|---|
Age (years) | 70 (34–84) | 57 (23–81) | 61 (32–79) | 0.41 |
Sex (male) | 7 (54) | 6 (75) | 11 (65) | 0.61 |
Weight (kg) | 70 (50–100) | 73.5 (55–135) | 75 (60–110) | 0.50 |
Reason of admission: | 0.27 | |||
Respiratory failure | 2 (15) | 5 (63) | 5 (29) | |
Circulatory failure | 3 (23) | 1 (13) | 2 (12) | |
Trauma | 2 (15) | 0 | 1 (6) | |
Post-resuscitation | 2 (15) | 0 | 2 (12) | |
Surgery | 4 (31) | 1 (13) | 7 (41) | |
AKI | 0 | 1 (13) | 0 | |
Sepsis | 5 (39) | 5 (63) | 7 (41) | |
SAPS II | 75 (43–112) | 47 (37–77) | 52 (32–86) | <0.001 |
SOFA | 14 (7–21) | 11 (8–15) | 13 (8–18) | 0.02 |
Mechanical ventilation | 12 (93) | 5 (63) | 7 (41) | 0.74 |
Norepinephrine (μg/kg/min) | 0.72 (0–2.8) | 0.15 (0–1.2) | 0.12 (0–1.1) | 0.20 |
ICU stay (days) | 5 (2–82) | 19.5 (4–48) | 20 (3–81) | 0.11 |
Mortality in ICU | 9 (69) | 1 (13) | 5 (29) | 0.02 |